Cantel Medical reported its second quarter fiscal year 2018 results.
Here's what you should know.
1. Cantel Medical had a record quarter. The company grew total sales by 15.3 percent year over year, with 10 percent organic growth.
2. The company's endoscopy division was the strongest performer, increasing sales by 23.6 percent.
3. Cantel ended the quarter with $40 million in cash and $160 million in gross debt.
4. Cantel's adjusted EBITDA increased 16.2 percent year over year.
5. Cantel's U.S.-based business also had a strong quarter with a 7.9 percent increase in 2017 over 2016's sales.
Cantel's President and CEO Jørgen B. Hansen said, "We are pleased to report record sales and earnings performance this quarter."